antileukemic
antileukemia
ponatinib
venetoclax
leukemogenicity
thioguanine
idelalisib
leukemogenic
leukemic
ubenimex
acute leukemia
chloraminophene
nonleukemogenic
leukemogenically
promyeloleukemia
pegaspargase
leukaemogenesis
chronic leukemia
leukemogenesis
acute lymphoblastic leukemia
trilaciclib
lenzilumab
tyrosine kinase inhibitor
vosaroxin
alemtuzumab
chemo
nonleukemic
clofarabine
leukaemic
chemoradioimmunotherapy
antideath
leukemoid
erythroleukemic
olutasidenib
aracytine
myeloid leukemia
chemoimmune
colorology
omacetaxine
chronic myelocytic leukemia
lymphosuppressive
lumiliximab
erythroleukemia
immunochemotherapy
talacotuzumab
antimalarial
homoharringtonine
chromotherapeutic
George Herbert Hitchings
506U78